Forecasts data is unavailable for this security.
Consensus recommendation
- 20-Jul-23
- 18-Apr-24
- 16-May-24
- 20-Jun-24
- 04-Jul-24
Select bar for recommendation details.
Recommendations | 04-Jul-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 6 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,207.65, with a high estimate of 2,829.82 and a low estimate of 1,869.63. The median estimate represents a 21.43% increase from the last price of 1,818.00.
High | 55.7% | 2,829.82 |
Med | 21.4% | 2,207.65 |
Low | 2.8% | 1,869.63 |
Dividends in USD
Div growth (TTM) | 30.11% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +10.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.99% |
More ▼